Buprenophine-wafer for drug substitution therapy

Details Buprenophine-wafer for drug substitution therapy Buprenophine-wafer for drug substitution therapy

A - Human Necessities

61

K

A61K 31/485 (2006.01) A61K 9/20 (2006.01) A61K 9/70 (2006.01) A61P 25/04 (2006.01)

Patent

CA 2661759

The present invention relates to oral pharmaceutical dosage forms comprising buprenorphine with the dosage form releasing buprenorphine instantly upon oral, preferably sublingual, application of the dosage form. The present invention also relates to the use of such dosage forms for treating pain in a human or animal or for drug substitution therapy in drug- dependent human subjects.

La présente invention concerne des formes orales pharmaceutiques comprenant de la buprénorphine, la forme pharmaceutique libérant instantanément la buprénorphine dès l'application orale de la forme pharmaceutique, de préférence sous la langue. La présente invention concerne également l'utilisation de telles formes pharmaceutiques pour le traitement de la douleur chez l'homme ou l'animal ou dans le cadre d'un traitement de substitution lié à la toxicomanie chez des sujets humains.

Affiliated with

Also associated with

Rating

Buprenophine-wafer for drug substitution therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Buprenophine-wafer for drug substitution therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Buprenophine-wafer for drug substitution therapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1603289